Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

Brain : a journal of neurology - 1 Nov 2009

Williams-Gray Caroline H, Evans Jonathan R, Goris An, Foltynie Thomas, Ban Maria, Robbins Trevor W, Brayne Carol, Kolachana Bhaskar S, Weinberger Daniel R, Sawcer Stephen J, Barker Roger A

Abstract excerpt

Cognitive abnormalities are common in Parkinson's disease, with important social and economic implications. Factors influencing their evolution remain unclear but are crucial to the development of targeted therapeutic strategies. We have investigated the development of cognitive impairment and dementia in Parkinson's disease using a longitudinal approach in a population-representative incident cohort (CamPaIGN...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Catechol O-Methyltransferase
Share to Cognition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition Disorders

Share to Dementia

Share to Dopamine

Share to Neuropsychological Tests

Share to Regression Analysis

Share to tau Proteins

Source

Identifiers

PMID: 19812213
DOI: 10.1093/brain/awp245

Genes

MAPT
COMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.PMID 19812213Read ↗

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.Semantic proximity Read ↗

APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.Semantic proximity Read ↗

APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's DiseaseSemantic proximity Read ↗

The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study.Semantic proximity Read ↗

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.Semantic proximity Read ↗

Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease.Semantic proximity Read ↗

Investigation of the genetic aetiology of Lewy body diseases with and without dementiaSemantic proximity Read ↗

Cognition among individuals along a spectrum of increased risk for Parkinson's disease.Semantic proximity Read ↗

Genetics of cognitive dysfunction in Parkinson's disease.Semantic proximity Read ↗

Genetic influences on cognitive decline in Parkinson's disease.Semantic proximity Read ↗

Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.Semantic proximity Read ↗

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.